INNOHEP 3500 IU/0.35ml Injection

Tinzaparin sodium
"10,000 IU/ml"
Leo Pharmaceutical Co.
Pack size 0.35ml Syringe x 10 (5's x 2)
Dispensing mode POM
Source DENMARK
AgentPHARMATRADE
Retail Price 160.00 AED

Indications

INNOHEP 3500 IU/0.35ml Injection is used for: Tinzaparin is used for the prevention of postoperative venous thromboembolism in patients undergoing orthopedic surgery and in patients undergoing general surgery who are at high risk of developing postoperative venous thromboembolism. It is also used for the treatment of deep vein thrombosis and/or pulmonary embolism. It is indicated for use in preventing clot formation in indwelling intravenous lines for hemodialysis

Adult Dose

Child Dose

Renal Dose

Administration

Contra Indications

Precautions

Pregnancy-Lactation

Interactions

Adverse Effects

Side effects of Tinzaparin sodium :

Mechanism of Action

Tinzaparin binds to the plasma protein antithrombin III, forming a complex with then accelerates the inhibition of factor Xa. Its affinity for factor Xa is 2-4 times greater than that of unbound ATIII. The inactivation of factor Xa in turn will exponentially generation of thrombin (factor IIa) molecules, which is needed to activate fibrinogen to fibrin. The coagulation cascade is inhibited because fibrin cannot be formed in the presence of tinzaparin. Like all LMWH, it cannot be given intramuscularly due to increased risk of hematoma

Note

INNOHEP 3500 IU/0.35ml "10,000 IU/ml" Injection manufactured by Leo Pharmaceutical Co.. Its generic name is Tinzaparin sodium. INNOHEP 3500 IU/0.35ml is availble in United Arab Emirates. Farmaco UAE drug index information on INNOHEP 3500 IU/0.35ml Injection is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Tinzaparin sodium :